China Isotope & Radiation Corp
HKEX:1763
China Isotope & Radiation Corp
Capital Expenditures
China Isotope & Radiation Corp
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China Isotope & Radiation Corp
HKEX:1763
|
Capital Expenditures
¥-534m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Capital Expenditures
¥-698.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-24%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Capital Expenditures
¥-891.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Capital Expenditures
¥-1.2B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Capital Expenditures
¥-322.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
See Also
What is China Isotope & Radiation Corp's Capital Expenditures?
Capital Expenditures
-534m
CNY
Based on the financial report for Dec 31, 2023, China Isotope & Radiation Corp's Capital Expenditures amounts to -534m CNY.
What is China Isotope & Radiation Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
7%
Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for China Isotope & Radiation Corp have been -9% over the past three years , 7% over the past five years .